Ubiquitin Proteasome pathway proteins as potential drug targets in parasite Trypanosoma cruzi

Area of Science:

• Parasitology and Molecular Biology
• Drug Discovery and Bioinformatics

Background:

• Trypanosomiasis affects millions globally, with growing drug resistance necessitating novel therapeutic strategies.
• The Ubiquitin Proteasome Pathway (UPP) is a validated target in other parasitic diseases, but its role in Trypanosoma cruzi remains underexplored.

Purpose of the Study:

• To conduct the first comprehensive survey of UPP enzymes and associated proteins in Trypanosoma cruzi.
• To identify potential novel drug targets within the T. cruzi UPP for anti-parasitic drug development.

Main Methods:

• Utilized extensive computational analyses and bioinformatics tools on the Trypanosoma cruzi genome and proteome data.
• Identified and characterized putative UPP proteins based on predicted subcellular localization, domain architecture, and expression profiles.

Main Results:

• Identified 269 putative UPP proteins in the T. cruzi proteome, including homologs in other Trypanosoma species.
• Characterized the T. cruzi UPP proteome, highlighting unique domain architectures and stage-specific expression patterns (amastigote).

Conclusions:

• The identified UPP proteins, particularly those with unique domain architectures and amastigote-specific expression, represent promising targets for novel anti-trypanosomal drug development.
• This comprehensive survey provides a foundation for future research into UPP function and therapeutic targeting in Trypanosoma cruzi.